Evaluating the Traditional Chinese Medicine (TCM) Officially Recommended in China for COVID-19 Using Ontology-Based Side-Effect Prediction Framework (OSPF) and Deep Learning

Ethnopharmacological relevance: Novel coronavirus disease (COVID-19) outbroke in Wuhan has imposed a huge influence onto the society in term of the public heath and economy. However, so far, no effective drugs or vaccines have been developed. Whereas, the Traditional Chinese Medicine (TCM) has been considered as a promising supplementary treatment for the disease owing to its clinically proven performance on many diseases even like severe acute respiratory syndrome (SARS). Meanwhile, many side-effect (SE) reports suggest the SE of the TCM prescriptions cannot be ignored in curing the COVID-19, especially because COVID-19 always simultaneously leads to dramatic degradation of the patients’ physical condition. How to evaluate the TCM regarding to their latent SE is a urgent challenge. Aim of the study: In this study, we use an ontology-based side-effect prediction framework (OSPF) developed in our previous work and Artificial Neural Network (ANN)-based deep learning to evaluate the TCM prescriptions that are officially recommended in China for novel coronavirus (COVID-19). Materials and methods: Firstly, we adopted the OSPF developed in our previous work, where an ontology-based model separate all the ingredients in a TCM prescription into two categories: hot and cold. Then, we established a database by converting each TCM prescription into a vector containing the ingredient dosage and the according hot/cold attribution as well as the safe/unsafe label. And, we trained the ANN model using this database, after which a safety indicator (SI), as the complementary percentage of side-effect (SE) possibility, is then given for each TCM prescription. According to the proposed SI from high to low, we re-organize the recommended prescription list. Secondly, by using this method, we also evaluate the safety indicators of some other famous TCM prescriptions that are not in the recommended list but are used traditionally to cure flu-like diseases for extending the potential treatments. Results: Based on the SI generated in the ANN model, FTS, PMSP, and SF are the safest ones Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 17 February 2020 © 2020 by the author(s). Distributed under a Creative Commons CC BY license. doi:10.20944/preprints202002.0230.v1

[1]  Xuan-Nam Bui,et al.  Developing a novel artificial intelligence model to estimate the capital cost of mining projects using deep neural network-based ant colony optimization algorithm , 2020, Resources Policy.

[2]  Kun Lu,et al.  An Ontology-Based Artificial Intelligence Model for Medicine Side-Effect Prediction: Taking Traditional Chinese Medicine as an Example , 2018, Comput. Math. Methods Medicine.

[3]  Hongzhou Lu,et al.  Drug treatment options for the 2019-new coronavirus (2019-nCoV). , 2020, Bioscience trends.

[4]  Hyun-Soo Shin,et al.  In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortex , 2007, Journal of Clinical Virology.

[5]  Guigang Zhang,et al.  Deep Learning , 2016, Int. J. Semantic Comput..

[6]  Shibo Jiang,et al.  Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China , 2020, Microbes and Infection.

[7]  Ahmed Habib,et al.  Updates on Wuhan 2019 novel coronavirus epidemic , 2020, Journal of medical virology.

[8]  Yongye Huang,et al.  Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science , 2019, Cancer medicine.

[9]  B. Beck,et al.  Predicting commercially available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China through a drug-target interaction deep learning model , 2020, bioRxiv.

[10]  Y. Zhang,et al.  Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms , 2017, Deutsche Zeitschrift für Akupunktur.

[11]  C. Krittanawong,et al.  Artificial Intelligence in Precision Cardiovascular Medicine. , 2017, Journal of the American College of Cardiology.

[12]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.